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The dsRNA-dependent protein kinase, PKR, is a key component of interferon (IFN)-mediated anti-viral action and is
frequently inhibited by many viruses following infection of the cell. Recently, we have demonstrated that IFN and PKR can
sensitize cells to apoptosis predominantly through the FADD/caspase-8 pathway (S. Balachandran, P. C. Roberts, T.
Kipperman, K. N. Bhalla, R. W. Compans, D. R. Archer, and G. N. Barber. (2000b) J. Virol. 74, 1513–1523). Given these findings,
it is thus plausible that rather than specifically target IFN-inducible genes such as PKR, viruses could also subvert the
mechanisms of IFN action, in part, at locations that could block the apoptotic cascade. To explore this possibility, we analyzed
whether the poxvirus caspase-8 inhibitor, CrmA, was able to inhibit IFN or PKR/dsRNA-mediated apoptosis. Our findings
indicated that CrmA could indeed inhibit apoptosis induced by both viral infection and dsRNA without blocking PKR activity
or inhibiting IFN signaling. In contrast HCV-encoded NS5A, a putative inhibitor of PKR, did not appear to inhibit cell death
mediated by a number of apoptotic stimuli, including IFN, TRAIL, and etoposide. Our data imply that viral-encoded inhibitors
of apoptosis, such as CrmA, can block the innate arms of the immune response, including IFN-mediated apoptosis, and
therefore potentially constitute an alternative family of inhibitors of IFN action in the cell. © 2001 Academic Press
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Innate immunity is a critical arm of pre-existing host
defense that functions to eliminate foreign pathogens
immediately after infection and subsequently directs the
adaptive immune response. Key components of innate
immunity, particularly against viral infection, are the in-
terferons (IFNs), a family of pleiotropic cytokines that are
divided into two major subtypes referred to as type I
(IFN-a/b) and type II (IFN-g; Stark et al., 1998). Upon viral
infection, the type I IFNs are transcriptionally activated
and following secretion bind to their cognate receptor in
either an autocrine or paracrine fashion. Dimerized IFN-
a/b receptors recruit Jak1 and Tyk2 and after phosphor-
lation mediate the activation of STAT1 and STAT2 on
hosphotyrosine residues (Darnell, 1998). The STAT 1
nd STAT 2 heterodimers subsequently complex with IFN
timulating growth factor 3 gamma (ISGF-3g/p48) form-
ng ISGF-3, which translocates into the nucleus and
inds to IFN stimulated response elements (ISREs)
ound in the promoters of IFN-induced genes. Through
his pathway, IFN-a/b can induce .30 genes responsi-
1 To whom reprint requests should be addressed at Rm. 514, Papa-
icolaou Building, 1550 NW 10th Ave. (M710), University of Miami
chool of Medicine, Miami, FL 33136. Fax: (305) 243-5885. E-mail:
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124le for producing IFN’s anti-viral and anti-proliferative
ffects (Stark et al., 1998).
Due in part to the growing number of IFN-induced
genes that are prevalent in the cell, the task of elucidat-
ing those critical genes responsible for mediating the
antiviral effects of these cytokines has remained a chal-
lenge. One of the well-characterized IFN-induced pro-
teins is the 68-kDa, dsRNA-dependent, serine/threonine
kinase, PKR, a protein frequently targeted by viruses for
inhibition (Meurs et al., 1990). PKR undergoes autophos-
horylation following interaction with dsRNA, which can
omprise viral genomes or replication intermediates with
ubstantial secondary structure. The kinase is then able
o phosphorylate target substrates, the best character-
zed being the alpha subunit of eukaryotic initiation factor
(eIF2a), which leads to the inhibition of protein synthe-
sis in the cell (Levin, 1978). In addition to this function,
PKR has been proposed to play a number of other roles
in the cell, including in the regulation of selective growth
factor signaling pathways and in the activation of NF-kB
through modulation of IkB kinase, IKKb (Yang et al., 1995;
Mundschau and Faller, 1995; Kumar et al., 1997; Chu et
al., 1999).
A consequence of activating PKR can include the in-
duction of apoptosis or programmed cell death, a natural
process required for development, homeostasis, and
protection from viral infection, malignant transformation,
or damaged cells. Cell death can be initiated from within
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125CrmA INHIBITS IFN-INDUCED APOPTOSISthe cell itself, as in the case of DNA or drug damage, or
through the ligation of death receptors such as Fas/
CD95/Apo-1, the tumor necrosis factor receptor (TNFR1),
or the TRAIL receptors DR4 and DR5. For example, liga-
tion of Fas to Fas ligand causes Fas receptor to trimerize
and recruit FADD (Fas-associated death domain contain-
ing protein), which then recruits caspase-8/FLICE
through its death effector domain (Chinnaiyan et al.,
1995; Boldin et al., 1996; Muzio et al., 1996). Caspase-8 is
able to initiate two possible death pathways, the first of
which includes the direct activation of effector caspases
such as caspase-3 (Salvesen and Dixit, 1999). An alter-
native caspase-8 pathway can occur through the mito-
chondrion via activation of Bid, a proapoptotic member of
the Bcl-2 family, which triggers a loss of mitochondrial
transmembrane potential and potential cytochrome c re-
lease. Cytochrome c is able to form a complex with
Apaf-1 and activate caspase-9 to cleave downstream
executioner caspase-3, leading to cell death (Li et al.,
1997).
To avoid killing their host cell, viruses such as bacu-
lovirus, adenovirus, simian virus 40, and several herpes
viruses have developed mechanisms to carefully orches-
trate the regulation of the apoptotic cascade (Roulston et
al., 1999). One of the best-characterized viral inhibitors is
poxvirus’ CrmA, which has been shown to be a potent
blocker of Fas and TNFa-induced cell death and func-
tions by blocking caspase-8 activity (Ray et al., 1992;
Tewari and Dixit, 1995). Recently, our group showed that
IFN and PKR appear to sensitize cells to apoptosis
through the FADD/caspase-8 pathway (Balachandran et
al., 2000b). Thus it is plausible that viral inhibitors of the
apoptotic pathway, such as CrmA, may also block an
important component of IFN-mediated antiviral activity.
Similarly, viral inhibitors of PKR may not only be prevent-
ing host-mediated translational repression but may also
be inhibiting a mechanism of IFN-mediated cell death.
It has also recently been reported that hepatitis C virus
(HCV) may inhibit PKR as a preventive measure against
the antiviral effects of IFN therapy. HCV, a member of the
Flaviviridae family, causes chronic liver disease in #85%
of infected individuals, and 1.5–5.0% of those patients are
estimated to develop hepatocellular carcinoma (Tanaka
et al., 1994; Tsukuma et al., 1993). IFN or IFN combined
with the nucleoside analogue ribavirin has been reported
to have an optimal success rate of ;40%, suggesting
that HCV may directly or indirectly invoke a mechanism
for subverting IFN action (Houghton, 1996). Accordingly,
reports have surfaced suggesting that NS5A may play a
role in repressing IFN activity (Enomoto et al., 1995,
1996). In this regard, IFN-resistant strains of HCV are
reported to encode a PKR binding domain, encompass-
ing the IFN-sensitivity-determining region (ISDR; aa
2209–2248), in the NS5A viral gene product (Gale et al.,
1998b). Yet another possible mechanism with which HCV
may subvert IFN action involves E2, an HCV glycoprotein,which has been reported to encode a PKR interacting
domain that prevents the phosphorylation of eIF2a (Tay-
or et al., 1999).
Here, we further evaluated the role of IFN and PKR in
ediating cell death as well as addressed whether the
iral-encoded inhibitors of host-defense, cowpox CrmA,
nd HCV NS5A are able to influence IFN-mediated apo-
tosis. To accomplish this, we used HeLa cell lines
nducibly expressing NS5A from IFN-resistant and -sen-
itive strains or expressing CrmA to examine the effects
f these viral genes on PKR activity, IFN-signaling, and
FN-mediated apoptosis. Our results demonstrate that
rmA, but not NS5A, is able to block cell death induced
y either dsRNA or virus infection. The mechanism of
rmA-mediated inhibition did not involve direct inhibition
f PKR or the IFN signaling pathway but functioned by
nhibiting the activity of the death-inducing signaling
omplex (DISC), which can regulate IFN-mediated cell
eath. Thus viral inhibitors of FADD-dependent apopto-
is may constitute an additional family of suppressors of
FN antiviral action in the cell.
RESULTS
rmA can block IFN-induced apoptosis
Since IFN- and PKR-mediated cell death has been
reviously shown by our lab to be dependent on recruit-
ent of the death adaptor molecule FADD, we examined
hether CrmA, a known inhibitor of caspase-8, was
apable of blocking PKR-mediated apoptosis (Balachan-
ran et al., 1998; Zhou et al., 1997). To evaluate this, we
stablished HeLa cell lines constitutively expressing
rmA in the vector pcDNA3 as well as control cell lines
ontaining vector alone. CrmA expression was con-
irmed by immunoblot analysis, and each experiment
as carried out using two independent cell lines to
inimize the risk of obtaining a non-specific phenotype
hat can occur during the selection process (Fig. 1A,
anes 3 and 4). To examine whether key apoptotic path-
ays were intact or defective in cells expressing CrmA,
r control cells carrying vector alone, cells were treated
ith Fas antibody, TNFa, or etoposide; this allowed us to
examine death receptor and mitochondria-mediated ap-
optosis, respectively (Faleiro et al., 1997; Li et al., 1997).
As has been previously described, CrmA overexpressing
cells were able to block apoptosis mediated through Fas
and TNFa but not by etoposide, which largely requires
mitochondrial input to trigger cell death (Tewari and Dixit,
1995; Fig. 1B). These results strongly indicate that our
cell lines express functional CrmA. To ensure that com-
ponents of the death-induced signaling complex (DISC)
were present and unaffected by transcriptional or trans-
lational constraints, expression of the pro-apoptotic pro-
teins, Fas, FADD, and caspase-8, were measured and
found to be approximately equal in each cell line exam-
ined (Medema et al., 1997; Srinivasula et al., 1996; Fig.
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127CrmA INHIBITS IFN-INDUCED APOPTOSIS1A). Our data suggest that differences in levels of apo-
ptosis were most likely due to CrmA blocking DISC
activity.
To evaluate CrmA’s ability to block virus-induced cell
death, each cell line was subsequently infected with
vesicular stomatitis virus (VSV) or influenza A virus, strain
WSN. Previous studies by our laboratory indicate that
WSN and VSV appear to induce apoptosis in murine
fibroblasts predominantly through the activation of DISC-
associated caspase-8 or mitochondria-associated
caspase-9, respectively (Balachandran et al., 2000b). Ac-
ordingly, our data indicated that HeLa cells expressing
rmA blocked WSN-induced apoptosis but not VSV-me-
iated death, indicating that only FADD-dependent killing
s predominantly affected (Fig. 1C). CrmA-expressing
ells were also transfected with the synthetic dsRNA,
oly(I:C), a potent activator of PKR and inducer of FADD-
ediated cell death that is commonly used to mimic viral
nfection. As expected, CrmA-expressing cells were also
ble to block dsRNA-induced apoptosis, an effect
trongly influenced by PKR (Balachandran et al., 1998;
Figs. 1C and 4). To investigate the influence of CrmA on
IFN-mediated cell death, control or CrmA-expressing
cells were treated with VSV or dsRNA in the presence or
absence of IFN. Our data revealed that IFN pretreatment
had no observable, adverse effect on control or CrmA-
expressing cells in the absence of dsRNA treatment
(data not shown). However, IFN-pretreated control cells
subsequently transfected with dsRNA resulted in almost
100% of the cells dying within 24 h compared to ;60% in
non-IFN-treated control cells (Fig. 2A). In contrast, CrmA-
expressing cells exhibited greatly reduced effects of IFN/
dsRNA action (approximately a 50% reduction in apopto-
sis compared to controls). CrmA did not affect VSV’s
ability to induce apoptosis, which we have shown occurs
in many cell types via activation of the mitochondria-
associated caspase-9 (Fig. 2A). Collectively, our data
indicate that CrmA can suppress IFN-mediated apopto-
sis.
CrmA has no effect on PKR activity or IFN signaling
Our data indicate that CrmA is able to inhibit dsRNA-
mediated cell death, an effect that is largely due to
activation of PKR (Balachandran et al., 1998; Der et al.,
997). To investigate whether the PKR in these cell lines
as functional, we analyzed the kinase’s ability to auto-
hosphorylate and phosphorylate its endogenous sub-
trate, eIF2a. CrmA-expressing cells were labeled in vivo
ith [32P]orthophosphate and transfected with poly(I:C),
hich potently induces the autophosphorylation of en-
ogenous PKR (Balachandran et al., 1998). PKR was
ubsequently precipitated using poly(I:C) agarose beads
r anti-PKR polyclonal antibody. These experiments indi-
ated that CrmA-expressing cell lines exhibited catalyti-
ally active PKR as demonstrated by the kinase’s abilityo autophosphorylate in response to activator (Fig. 2B,
anes 2, 4, 6). It is documented, however, that certain
iral-encoded PKR inhibitors do not directly affect PKR’s
bility to autophosphorylate but rather prevent the kinase
rom phosphorylating its targets. To investigate this pos-
ibility, lysates from the above in vivo labeling experi-
ment (Fig. 2B) were analyzed for eIF2a phosphorylation
n Ser51 using a phospho-specific antibody to eIF2a
(DeGracia et al., 1997). Our data indicated that both of the
ontrol or CrmA-expressing cells exhibited phosphory-
ated eIF2a to varying levels after treatment with dsRNA
Fig. 2C, lanes 2, 4, 6). Total eIF2a levels were confirmed
as being equal in the treated and untreated cells (Fig.
2C). These data strongly indicate that neither PKR’s auto-
or trans-phosphorylation activity is impeded by CrmA
expression.
Type I IFN has been shown to potentiate apoptosis in
response to dsRNA (Balachandran et al., 2000b). To en-
sure that CrmA was not inhibiting IFN function, we ex-
amined whether CrmA had any effect on IFN signaling
and thus the induction of IFN-induced genes. Accord-
ingly, to ensure that IFN-induced gene expression was
indeed normal, CrmA-expressing cells were treated with
IFN-a for 4 or 8 h, and the expression of PKR, a key
IFN-inducible gene was monitored. Our data indicated
that PKR expression was significantly increased in each
of the cell lines irrespective of whether CrmA was
present or not (Fig. 2D). Densitometric analysis indicates
that PKR levels rose ;2.5 fold after 8 h of IFN treatment
in the CrmA-expressing cells and threefold in the con-
trols (Fig. 2E). This translational readout indicates that
the Jak/STAT IFN-signaling pathway is almost certainly
functional and unimpeded by CrmA. Collectively our data
infer that CrmA blocks IFN/dsRNA-mediated apoptosis
downstream from IFN-gene induction and largely at the
level of apoptotic, FADD-dependent signaling.
Examination of HCV NS5A in the regulation of
apoptosis
Our studies indicated that CrmA is an inhibitor of
dsRNA-PKR-mediated apoptosis but not of PKR itself. To
complement these studies, we sought to analyze
whether a reported viral-encoded PKR inhibitor, NS5A,
also blocked PKR-induced apoptosis. To address this,
we used HeLa cell lines that inducibly express NS5A
isolated from both IFN responsive (les 5-genotype 1b)
and non-responsive patients (1b11-genotype 1b and 1a6,
1aD5-genotype 1a; Polyak et al., 1999, 2001). The 1aD5
cell line contains an ISDR deletion mutant that lacks the
first 40 amino acids responsible for binding to PKR. The
repression of protein expression is dependent on the
presence of tetracycline or its analogue doxycycline. In
the absence of doxycycline, these cell lines overex-
pressed NS5A, as shown in Fig. 3A.
Once we had confirmed inducible expression, we
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129CrmA INHIBITS IFN-INDUCED APOPTOSISevaluated NS5A’s inhibition of PKR by carrying out in vivo
abeling experiments with transfected dsRNA. Our re-
ults indicated that PKR underwent autophosphorylation
hether NS5A expression from either an IFN responder
les5), non-responder (1b11 and 1a6), or missing the
SDR (1aD5) was repressed or not (Fig. 3B). To determine
f NS5A was able to inhibit PKR at the level of substrate
ctivation rather than autophosphorylation, we analyzed
IF2a phosphorylation in NS5A-expressing cells, in re-
ponse to dsRNA. Again, we did not appreciably detect
ny inhibition of PKR activity in any of the NS5A-express-
FIG. 3. (A) Inducible NS5A expression in HeLa cells. Tetracycline-
(Clontech, Ca). Tetracycline (or doxycycline) represses protein express
lines containing NS5A derived from HCV-positive patients that respon
et al., 1999, 2001). 1aD5 has a deletion mutation that removes the ISD
domain. The control cells are the parental cell line for all of the inducib
patients. (B) PKR autophosphorylation analysis in NS5A-expressing cel
The autocatalytic activity of the appeared unperturbed in cells exp
phosphorylates eIF2a in NS5A expressing cells. Extracts of dsRNA-tre
using an antibody that recognizes phosphorylated serine 51.ng cell lines (Fig. 3C). Our data would indicate that these
articular cell lines, which inducibly express various rep-
i
mesentations of HCV NS5A, do not appear to contain
ompromised PKR/eIF2a activity in response to dsRNA
treatment or to VSV infection (data not shown).
To further explore NS5A’s potential role in the regula-
tion of apoptosis, such as whether this HCV product
influenced dsRNA-induced cell death, each cell line was
treated with poly(I:C) in an induced and uninduced state,
in the presence and absence of IFN. Principally, our data
did not indicate that IFN-signaling or -induced gene
expression was impaired in NS5A-expressing cells
(Polyak et al., submitted). In addition, HeLa cells express-
le cells expressing NS5A were developed using Tet Off HeLa cells
ile the absence of dox allows dramatic overexpression of NS5A. Cell
s5) or did not respond (1b11, 1a6, and 1aD5) to IFN treatment (Polyak
5A, which coincides with the first 40 amino acids of the PKR binding
. Immunoblots were generated using human serum from HCV-positive
was 32P-labeled in vivo in each cell line after transfection with dsRNA.
g NS5A from IFN responsive and unresponsive patients. (C) PKR
lls from (B) were examined for eIF2a phosphorylation by immunoblotinducib
ion wh
ded (le
R of NS
le cells
ls. PKR
ressinng NS5A did not appear to exhibit a defect in IFN-
ediated inhibition of VSV-induced apoptosis compared
c
w
t
(
K
(
l
130 EZELLE ET AL.to cells in an uninduced state (data not shown). Further-
more, as can be seen in Fig. 4, dsRNA-mediated apo-
ptosis did not appear inhibited in cells overexpressing
NS5A, and .90% of the cells died within 24 h of treat-
ment. The effect of dsRNA was so dramatic that the
addition of IFN, which enhances FADD-dependent,
dsRNA-mediated cell death was masked (data not
shown). Collectively, our data indicate that NS5A did not
effectively prevent these cells from undergoing dsRNA-
mediated apoptosis.
Finally, to further examine the apoptotic pathways of
each of the inducible NS5A cell lines, cells were treated
with the death ligand TRAIL and etoposide in the induced
and uninduced states. Following binding to death recep-
tors (DR) 4 and 5, TRAIL, like Fas, proceeds through the
FADD/caspase-8 pathway while, as mentioned, etopo-
side induces DNA damage to activate mitochondria and
release cytochrome c. As can be seen in Fig. 5, all of the
cell lines underwent apoptosis when treated in the un-
FIG. 4. Analysis of dsRNA-induced cell death in NS5A and CrmA-
expressing cell lines. Each cell line was transfected with poly I:C and
then examined for apoptosis 15 h post-transfection. Cell death was
analyzed by trypan blue exclusion. Apoptosis of the NS5A cells was
always examined in both the induced and uninduced states to rule out
differences due to clonal variation. Neither NS5A from a responder
(les5) or a non-responder (1b11, 1a6) patient was able to inhibit apo-
ptosis, in contrast to CrmA.induced state, although clonal variation caused overall
levels to somewhat vary. When NS5A was expressed,only slight variations were detected in TRAIL and etopo-
side killing, none of which correlated with IFN respon-
siveness (Figs. 5A and 5B).
K3L but not the ISDR of NS5A binds to PKR
NS5A has been reported to contain a stretch of 40
amino acids termed the IFN-sensitivity determining
region (ISDR) that has been proposed to bind to PKR
and to correlate with virus resistance to IFN therapy
(Gale et al., 1998a). To further investigate the potential
inhibitory properties of the ISDR domain of NS5A, on
PKR, we employed a coupled in vitro kinase assay
using a model peptide substrate. A number of exper-
iments with peptides representing PKR revealed that
the peptide n-GRSRSRSRSR-c served as an effective
substrate (K m 5 431 6 85 mM; Fig. 6A). Using the
oupled assay, an intrinsic ATPase activity for PKR
as observed, but this was not significant compared
o the consumption of ATP by peptide phosphorylation
data not shown).
We first assessed whether vaccinia virus-encoded
3L, purified as described under Materials and Methods
Fig. 6C), was able to inhibit PKR-mediated phosphory-
ation of the model peptide. Previous data have shown
FIG. 5. NS5A HeLa cell lines are susceptible to TRAIL and etoposide-
mediated apoptosis. Cells were treated in both the induced (2Dox) and
uninduced (1Dox) states. Cell death analysis was conducted by trypan
blue exclusion and is expressed as percentage of cells killed.
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131CrmA INHIBITS IFN-INDUCED APOPTOSISthat K3L can inhibit PKR phosphorylation of histone IIA
and eIF2a (Carroll et al., 1993; Davies et al., 1992). Ac-
cordingly, in Fig. 6A, we observed that at a concentration
of 9.5 mM, K3L functioned as a potent competitive inhib-
tor of peptide phosphorylation. We next examined
hether the highly purified ISDR region could inhibit the
bility of PKR to phosphorylate the model peptide sub-
trate. However, data did not indicate that this portion of
he NS5A could inhibit PKR function (Fig. 6B). In fact at
he highest concentration that we were able to test (53
mM), NS5A appeared to have a small stimulatory effect
on PKR kinase activity. Although we cannot rule out that
other portions of the NS5A product may be required to
facilitate binding or that the purified ISDR may not be
conformationally authentic, our data infer that amino ac-
FIG. 6. Lineweaver-Burk Plots (1/[S] vs 1/[V]). Inhibition of PKR acti
he substrate concentrations and velocities are derived from the phosph
t 0.2 and 0.6 mM in the presence or absence of K3L at 9.5 mM concentr
(B). (C) Coomassie stains of purified K3L and NS5A fragment.ids 2179–2292 of HCV NS5A do not effectively inhibit PKR
function in vitro (Gale et al., 1998a).DNA array of NS5A expression
NS5A has been reported to possess transactivation
activity when fused to the Gal4 DNA binding domain
(Kato et al., 1997; Fukuma et al., 1998; Tan et al., 1999).
However, its proposed function in viral replication has
yet to be defined and its affects on the host cell are still
being elucidated. Therefore, to further explore NS5A’s
role in viral pathogenesis and in regulating gene expres-
sion, we conducted a microarray analysis using the 1b11
(NS5A from a IFN treated non-responder) inducible cell
line. HeLa cells expressing NS5A 1b11 were induced for
5 days, and NS5A expression was confirmed by immu-
noblot to ensure tight inducibility (Fig. 3A). The mRNA
from uninduced cells and cells induced to express NS5A
vaccinia virus K3L but not HCV NS5A/ISDR. Lineweaver-Burk plots of
n of RSRSRRSRSR peptide by PKR. Peptide concentrations were varied
) or an ISDR containing NS5A protein fragment at 53 mM concentrationvity by
orylatiowas isolated, fluorescently labeled, and hybridized to a
DNA microarray containing ;10,000 genes (Alizadeh et
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132 EZELLE ET AL.al., 2000; Iyer et al., 1999). Our results, however, did not
indicate that NS5A expression appreciably regulated any
genes at the level of transcription. Three expressed se-
quence tags (ESTs) of unknown function were regulated
twofold, one of which exhibited homology to the Dro-
sophila ariadne-2 gene, a member of a protein family that
contains the Acid-rich, Ring finger, B-box, RING finger,
coiled-coil (ARBRCC) motif string (Aguilera et al., 2000).
The remaining two upregulated genes were keratin 14, a
member of the intermediate filament superfamily, and the
type I inositol 1,4,5-trisphosphate receptor (IP3R), a Ca
21
release channel on intracellular Ca21 storage sites such
as the endoplasmic reticulum (data not shown). Interest-
ingly, no genes appeared to be downregulated by NS5A
in HeLa cells greater than twofold, including a number of
IFN-regulated genes such as STAT-1, PKR, and the 29,59
-oligoadenylate synthetase (data not shown). However,
ince IFN likely induces the expression of a number of
enes, it remains conceivable that as yet uncharacter-
zed, key antiviral-induced IFN-regulated genes may be
argeted by NS5A that are not represented on the DNA
rray. Nevertheless, our data provide a start towards
urther examination of the efficacy of DNA array technol-
gy in understanding the function of HCV gene products
n the cell.
DISCUSSION
The IFNs constitute an intricate component of the
nnate immune system’s ability to defend the host
gainst viral infection (Muller et al., 1994; Durbin et al.,
996). Although the mechanisms of IFN-mediated antivi-
al activity remain to be fully clarified, our laboratory has
ecently shown in vitro that IFN-a/b is able to sensitize a
umber of cell types to FADD-dependent apoptosis (Bal-
chandran et al., 2000b). The investigation of IFN-medi-
ated death could include a role for PKR since, aside from
regulating the activity of eIF2a, activation of PKR, which
s an IFN-induced gene, can also lead to the induction of
ADD-mediated apoptosis (Balachandran et al., 1998). It
s not yet clear whether PKR mediates cell death through
n eIF2a-dependent pathway or through an as yet un-
larified mechanism involving another signaling path-
ay. However, activation of PKR has been reported to
oincide with the stimulation of Fas expression, which
resumably escapes stringent translational or post-
ranslational constraints imposed by this kinase in the
ell (Balachandran et al., 1998; Donze et al., 1999).
Given these findings, we postulated that viral-encoded
nhibitors of apoptosis such as CrmA, a well-known in-
ibitor of caspase-8, may also be able to inhibit this
omponent of IFN antiviral action, namely the induction
f cell death (Quan et al., 1995; Ray et al., 1992). We
eport here that CrmA could indeed inhibit dsRNA and
FN-mediated cell death almost certainly downstream
rom IFN signaling and induced gene expression and at
m
she level of DISC activity. For example, dsRNA-induced
ell death, which is potently augmented by PKR, was
locked in CrmA-expressing cells even though the inter-
eron inducibility of PKR as well as activity of this kinase
as unaffected. Given these data, it is further plausible
hat in addition to CrmA, other viral-encoded DISC inhib-
tors such as the vFLIPS and E1B-19K encoded by pox-
iruses and herpesviruses, respectively, (Roulston et al.,
999) may repress IFN-mediated apoptosis (Fig. 7).
However, it has further been reported that cells may
ndergo DISC-associated cell death through two poten-
ial mechanisms. For example, in cells referred to as type
, such as SKW6.4 or H9, DISC activity is strongly acti-
ated in response to apoptotic stimuli leading to direct
ctivation of executioner caspase-3. Conversely, in type
I cells, such as Jurkat and CEM, activation of the DISC is
ot efficient, and activation of caspase-3 proceeds pre-
ominantly through the mitochondria and can be blocked
y Bcl-2 (Scaffidi et al., 1998). Thus it is also possible,
hat in certain cells, viral-encoded inhibitors of mitochon-
rial-mediated cell death such as the Epstein–Barr Virus
HRF-1 or HHV-8-encoded KSBcl-2 (Henderson et al.,
993; Cheng et al., 1997) may also play a role in prevent-
ng IFN-induced anti-viral action (Fig. 7).
It has been previously reported that since many HCV-
nfected individuals do not respond to IFN therapy, HCV
ay have devised mechanisms to circumvent the antivi-
al action of these cytokines. While this escape from IFN
herapy may well involve a component of the adaptive
mmune response, much focus has gone into elucidating
potential way in which the intracellular antiviral com-
onents of IFN action may be compromised by this virus.
or example, a region within the NS5A region, termed the
SDR, has been found to correlate with IFN responsive-
ess in Japanese patients infected with HCV (Enomoto et
l., 1995, 1996). Subsequently, it has been reported that
S5A variants from HCV-infected patients not respond-
ng to standard IFN therapy may have evolved to inhibit
he antiviral activity of PKR. Although our data do not
upport that NS5A may directly inhibit PKR, this may be
result of cell-specific or clonal differences in our cell
ines that inducibly express NS5A variants as well as
ariations in the described assay protocols. For example,
ur data do not indicate significant differences in dsRNA-
nduced apoptosis or PKR activity whether the NS5A
epresents a non-responsive patient (genotypes 1a and
b), a patient who did respond to IFN therapy (genotype
b), or a non-responsive isolate that is lacking the ISDR
genotype 1a). Possibly the method of dsRNA-induced
poptosis, which in our hands involves liposome trans-
ortation, is very efficient, and a certain proportion of
KR may become active and overwhelm the cell to the
oint that NS5A is not able to interact with and inhibit
very PKR molecule. Thus, low levels of activated PKR
ay remain available to homodimerize, which may be
ufficient to induce apoptosis. Alternatively, it was re-
(o
(
ed, 200
mediate
133CrmA INHIBITS IFN-INDUCED APOPTOSIScently demonstrated that IRF-3, a transcriptional factor
potently activated by dsRNA can also induce apoptosis
in an IFN-independent manner (Heylbroeck et al., 2000).
Nevertheless, our data would be in agreement with the
results of Franc¸ois et al., who showed that osteosarcoma
cells inducibly expressing the entire HCV genome, with
corresponding proteins, do not appear to exhibit dimin-
ished PKR activity if stimulated with heparin or poly(I:C)
(Franc¸ois et al., 2000). In addition, IFN has been shown to
rapidly inhibit HCV RNA replication regardless of the
presence or absence of the ISDR region (Blight et al.,
2000). Again, it is plausible that NS5A may require cell-
specific factors present only in hepatocytes to assist in
any inhibitory role or even require other HCV-encoded
gene products to be effective. In addition, since PKR has
been proposed to play a number of roles in the cell, it
remains plausible that NS5A may inhibit the IFN system
by other mechanisms or prevent the interaction of PKR
with alternate substrates in other signaling pathways.
In an effort to further elucidate NS5A’s possible roles
in pathogenesis and possibly tumorigenesis, however,
we carried out a DNA array analysis on HeLa cells
inducibly expressing NS5A. We observed that two genes
FIG. 7. Interferon and dsRNA can mediate FADD-dependent apoptos
f numerous interferon-activated genes in the cell, including PKR. This
Balachandran et al.). Viral dsRNAs can additionally activate IRF-3, whi
Cowpox CrmA blocks FADD-dependent apoptosis, which can be trigg
caspase-8. Normally, caspase-8 can induce apoptosis by directly activ
also recruit mitochondrial input into the induction of cell death by
pro-caspase-9 to activate caspases 2, 3, 6, 7, 8, and 10 (Kroemer and Re
and Kaposi’s sarcoma virus (HHV-8) KsBcl-2 can inhibit mitochondria-referred to as keratin 14 and type 1 inositol 1,4,5-trisphos-
phate receptor (IP3R) were moderately upregulated byNS5A expression (data not shown). It has been previ-
ously reported that cytokeratin 14 has been found in a
majority of HCC cases that also express biliary markers
AE1/AE3 and cytokeratin 19, suggesting that such HCCs
may have de-differentiated back to their bipotential pro-
genitor cell phenotype during transformation (Wu et al.,
1999). Whether keratin 14 expression is merely a char-
acteristic of HCC or a contributor, however, has yet to be
determined (Lloyd et al., 1995; Sinha et al., 2000; Wu et
al., 1999). Interestingly, a recent study has shown that
induced liver fibrosis and cirrhosis can lead to an in-
crease in isoforms 1 and 3 but not isoform 2 of the IP3R
Dufour et al., 1999). Again, whether this is a cause or
result of liver injury is not yet known. Furthermore, the
significance of the moderate upregulation of these genes
in HeLa cells has yet to be determined. In addition to
these findings, preliminary investigations did not reveal
that NS5A transcriptionally repressed known molecular
associates of the IFN-signaling pathway or induced
genes or key members of the apoptotic pathway. Despite
the fact that our data would suggest that the properties of
NS5A, which have been reported to involve a role in
signaling, does not affect DISC mediated apoptosis,
dsRNAs can activate interferon production and induce the expression
an lead to the induction of apoptosis via activation of FADD/caspase-8
gh gene induction can also trigger apoptosis (Heylbroek et al., 2000).
y dsRNA or death ligands such as TRAIL, by inhibiting the activity of
xecutioner caspase-3 as well as caspases 2, 6, and 7. Caspase-8 can
ing Bid, which induces cytochrome c to release Apaf-1 modulated
0). Viral encoded products such as Epstein–Barr virus-encoded BHRF1
d apoptosis.is. Viral
event c
ch throu
ered b
ating e
activatthese results do provide a start towards attempting to
evaluate the role of HCV gene products in the cell.
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134 EZELLE ET AL.Analysis of HCV gene expression in hepatocyte-derived
cells at various time points post-expression may yield
further information into the regulation of cellular gene
expression by this virus.
MATERIALS AND METHODS
Cell lines
The tetracycline inducible Hela cell lines expressing
NS5A 1b11, 1a6, and 1aD5, and NS5A les5, have been
previously described (Polyak et al., 1999, 2001). NS5A
ariants were cloned into the pTRE vector (Clontech), in
hich protein expression is under the control of a tTA-
esponsive, minimal cytomegalovirus promoter (Gossen
t al., 1995). Hela Tet-off cells were maintained in Dul-
ecco’s modified Eagle medium (DMEM) containing 10%
etal bovine serum (FBS; Gibco-BRL, Gaithersburg, MD),
mM L-glutamine (Gibco), 13 antibiotic-antimycotic (100
nit/ml penicillin G, 100 mg/ml streptomycin sulfate, 0.25
mg/ml Fungizone; Gibco), and 5 mg/ml doxycycline (Dox;
igma, St. Louis, MO). For protein induction, cells were
ashed five times with phosphate-buffered saline (PBS)
nd incubated for 4 days in DMEM lacking Dox, supple-
ented with FBS. Induction was verified by immunoblot
nalysis using human serum from HCV-positive patients.
CrmA-expressing cell lines were generated by trans-
ecting pcDNA3CrmA (a gift from Lawrence Boise) into
ela cells using Lipofectamine PLUS (Gibco-BRL). After
3-h incubation, the transfection medium was replaced
ith DMEM and 10% FBS. The cells were allowed to
ecover for 24 h before transfectants were selected for
ith 1000 mg/ml G418 (Gibco-BRL). Colonies were iso-
ated and expanded. CrmA expression was identified by
mmunoblot analysis of cell extracts using anti-CrmA
ntibody (Pharmingen, San Diego, CA).
mmunoblot analysis
Immunoblot analyses were performed as described by
alachandran et al. (1998). Protein extracts were pre-
ared in lysis buffer I (20 mM Tris–HCl (pH 7.5), 50 mM
Cl, 400 mM NaCl, 1% (v/v) N-P40, 1 mM EDTA, 1 mM
ithiothreitol (DTT), 1 mM phenylmethylsulfonylfluoride
PMSF), 10 unit/ml aprotinin, 10 unit/ml leupeptin, and 25
M NaF). Protein concentration was determined by Coo-
assie Protein Assay Reagent (Pierce Chemicals, Rock-
ord, IL). Cell extracts were then separated by sodium
odecyl sulfate polyacrylamide gel electrophoresis
SDS–PAGE) and transferred to nitocellulose. Proteins
ere detected with primary antibodies to CrmA and
b-tubulin (Pharmingen), human PKR (a gift from Ara
Hovanessian), eIF2a phosphorylated and unphosphory-
lated (Carroll et al., 1993; DeGracia et al., 1997), Fas,
FADD, and caspase-8 (Santa Cruz, Palo Alto, CA) and
human serum from HCV-positive patients to detect NS5A
(Polyak et al., 1999). Secondary antibodies to mouse, arabbit, and human were conjugated to horseradish per-
oxidase (Jackson ImmunoResearch, West Grove, PA) and
visualized with chemiluminescence substrate (Pierce
Chemicals).
Apoptosis and cell viability analysis
DsRNA (poly(I:C); Amersham Pharmacia Biotech, Pis-
cataway, NJ) was prepared as previously described (Bal-
achandran et al., 2000a) and transfected using Lipo-
fectamine PLUS (Gibco). Cells were transfected with 0.7
mg/0.5 ml DMEM, in the absence of FBS, for 3 h. Trans-
fection medium was replaced with DMEM and 10% FBS.
At 15 h post-transfection, cell viability was analyzed by
trypan blue exclusion.
Fas killing was induced by treating cells with anti-
human Fas monoclonal antibody (Kamiya Biomedical
Company, Seattle, WA) at 2 mg/ml and protein A, also at
mg/ml. TNFa was used at 10 ng/ml with 2 mg/ml
cyclohexamide, and etoposide treatment was 100 mM
(Sigma). TRAIL-mediated killing was done using 100
ng/ml soluble TRAIL (Kamiya). Cell viability was analyzed
by trypan blue exclusion at 16, 36, and 48 h, respectively.
Viral infections and titration
Vesicular stomatitis virus (VSV, Indiana strain) and
influenza virus (WSN) infections and plaque assays were
performed as previously described (Balachandran et al.,
2000b). Cells were infected with virus at a m.o.i. of 10 for
cell viability assays and viral titres. Viability was assayed
by trypan blue exclusion.
Analysis of PKR phosphorylation in vivo
Hela cells (5 3 106) were transfected with 7 mg
poly(I:C) using Lipofectamine PLUS and labeled with 200
mCi/ml [32P]orthophosphate (Amersham Pharmacia Bio-
ech) for 4 h in phosphate-free DMEM (Gibco). Labeled
ells were then lysed in Buffer II [25 mM Tris (pH 7.5), 25
M KCl, 400 mM NaCl, 1% (v/v) N-P40, 1 mM EDTA, 1
M DTT, 25 mM NaF, 200 mM PMSF, 10 unit/ml aprotinin]
or 5 min, sonicated, and clarified by centrifugation. Ly-
ates were then pre-cleared with agarose beads prior to
ncubation with poly(I:C)–agarose (Amersham Pharmacia
iotech) for 2 h with rotation at 4°C. The poly(I:C)–
garose beads were washed extensively with Buffer II,
nd bound protein was eluted by boiling in SDS protein
enaturing buffer [50 mM Tris–HCl (pH 6.8), 100 mM DTT,
% (w/v) SDS, 10% glycerol, 0.05% (w/v) bromphenol
lue], resolved by SDS–10% PAGE, and visualized by
utoradiography.
acterial expression and purification of PKR, NS5A,
nd K3LThe catalytic domain of PKR (residues 242–551) and
n IFN-sensitivity determining region (ISDR)/PKR binding
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135CrmA INHIBITS IFN-INDUCED APOPTOSISdomain containing fragment of NS5A (residues 2179–
2292) were expressed in Escherichia coli as GST fusion
roteins using derivatives of the pGEX-2T vector (Phar-
acia). We have modified this vector to facilitate the
leavage of GST protein fusions using the TEV protease.
usion constructs were transformed into BL21 bacteria
nd grown at 37°C to an optical density of 0.6. Protein
xpression was induced with 0.5 mM IPTG overnight at
oom temperature. The harvested cells were suspended
n PBS with 0.2 mM PMSF, 3 mM MgCl, 100 Kunitz
nits/ml DNaseI (Roche), and lysed with an Emulsi-
lex-C5 homogenizer (Avestin). Lysates were clarified by
entrifugation and incubated with glutathione sepharose
Pharmacia) in batch. After extensive washing with PBS,
he fusion proteins were cleaved from the sepharose
atrix using TEV protease as directed by the manufac-
urer (Life Technologies).
Cleaved proteins were eluted and diluted threefold
ith buffer A (20 mM HEPES, pH 8.0) and loaded onto a
ml Hi-Trap S column (Pharmacia). PKR, which does not
ind to the Hi-Trap S column, was concentrated and
oaded onto a Sephadex 75 gel filtration column (Phar-
acia) equilibrated in 20 mM HEPES, pH 7.5; 150 mM
Cl; and 1 mM DTT. Elution fractions containing PKR
ere pooled, concentrated to 20 mg/ml, and flash frozen
n liquid nitrogen for storage at 280°C. NS5A, which
inds to the Hi-Trap S column, was eluted by a linear
radient against Buffer A with 1 M KCl. Fractions con-
aining NS5A were pooled, concentrated, and loaded
nto a Superdex 75 sizing column as described for PKR.
lution fractions containing NS5A protein were pooled,
oncentrated to 70 mg/ml, and flash frozen in liquid
itrogen. All kinetic experiments were performed with
he TEV-cleaved form of PKR and NS5A. K3L was ex-
ressed and purified as previously described (Carroll et
l., 1993). After cleavage with TEV, the liberated NS5A
nd PKR proteins possessed the non-native n-terminal
equence gly, ala, his, met.
pectrophotometric coupling assay
Kinetic analysis of bacterial expressed PKR was per-
ormed using a coupled in vitro kinase assay. In this
ssay ADP is coupled to the oxidation of NADH through
yruvate kinase (PK) and lactate dehydrogenase (LDH;
arker et al., 1995). The 100-ml reaction volume con-
ained 1 unit of LDH, 1 unit PK, 1 mM phosphoenolpyru-
ate, 0.2 mM NADH and 2 mM ATP in 20 mM MgCl2; 0.2
mM DTT; 60 mM HEPES, pH 7.5, and 20 mg/ml BSA.
Preliminary experiments ensured that the concentration
of the kinase (0.008 mg/ml) was the rate-limiting compo-
nent. Concurrent reactions were followed at 340 nm on a
Hewlett-Packard 845-UV-Visible 7-Cell system. Protein
concentration was determined by UV spectrometry at
280 nm using molar extinction coefficients calculated for
each protein.Enzyme kinetics
Kinetic constants were determined under pseudo-sin-
gle substrate conditions using the general rate equation
of Alberty for multi-substrate systems (Segel, 1975); v 5
vmax[ax][bx]/kmb[ax] 1 kmax 1 [ax] 1 (ksax)(kmb)
here, vmax 5 the maximal velocity when ax and b are
t saturating concentration; km 5 the concentration that
ives rise to 1/2 vmax when the second substrate is
aturating; ksax 5 the dissociation constant for E 1
X 3 EAX.
At saturating concentrations of B, the general equation
implifies to a pseudo-single substrate system as fol-
ows: V 5 VMAX/(1 1 KMAX/[B]) 5 VMAX[AX]/[AX] 1
MAX (the Michaelis Menton equation). Kinetic con-
tants were extrapolated from Lineweaver-Burk plots of
/[S] vs 1/[V]. All reactions were repeated eight times.
NA array of NS5A
HeLa cells expressing NS5A 1b11 were induced for 5
ays in the absence of doxycycline. Approximately 8 3
06 cells were then harvested for mRNA isolation using
mersham-Pharmacia’s QuickPrep mRNA Purification
it. MRNA from cells expressing or not expressing NS5A
b11 was then prepared according to Incyte’s specifica-
ions and sent to them for microarray analysis (Alizadeh
t al., 2000; Iyer et al., 1999).
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